Skip to content
Arena Space UK

Patients Coming Off Anti-Obesity Medications Put On Weight Far More Rapidly Compared to Those on Conventional Diets

Illustration of pharmaceutical syringe and weighing machine
Weight management often requires long-term strategies.

A recent study reveals that individuals who come off popular slimming jabs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who end conventional diet and exercise plans.

Published data in a prominent medical journal demonstrates that while overweight people often shed about a fifth of their body weight while using the jabs, the mass comes back at an average rate of nearly a kilo each month once they quit.

"People using these drugs need to be informed of the danger of quick weight regain when the treatment concludes," warns expert Dr. Susan Jebb.

Such speed of recovery means a return to original mass in about a year and a half.

Comparing Therapies

The research, which examined dozens of studies involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with other pills.

Scientists point out that people who lose weight through dieting typically see a less rapid weight regain—perhaps 100 grams monthly—once they finish.

Understanding the Quick Regain

Nutrition scientists believe the way of the drugs is key to understanding the heightened rebound.

The injections imitate a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement leads to hunger is uncontrolled, making excessive eating far more likely."

A Lifelong Disease?

The NHS suggest the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.

A number of clinicians contend that, due to the high risk of weight regain, the therapy might need to be long-term.

This opinion is supported by pharmaceutical companies, who note that the results "highlight the persistent character of obesity," similar to managing diseases like hypertension.

User Experiences

Users who have discontinued the jabs report a powerful return of hunger.

"It was like a switch activating and you become starving," recalled a patient.

The struggle is exacerbated if patients have not established sustainable lifestyle or habit modifications during therapy.

Growing Use

Recent estimates show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.

  • Use is more common among females than men.
  • The 40s and 50s age group shows the highest level of interest.
  • A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, researchers caution that while these medications are effective agents for shedding pounds, they are not a standalone solution and lasting health benefits relies on ongoing lifestyle support.

SD
Written by

Susan Deleon

James Carter is a certified fitness coach and wellness advocate with over a decade of experience in transforming lives through exercise and nutrition.

Arena Space UK

Type to search articles.